Izrael - engleski - Ministry of Health

padagis israel pharmaceuticals ltd, israel - fluvoxamine maleate - tablets - fluvoxamine maleate 50 mg - fluvoxamine - fluvoxamine - for the treatment of affective disorders characterized by persistent low mood, impaired psychomotor atctivities and psychomatic complaints including symptoms of depression. treatment of obsessive compulsive disorders (ocd).

Izrael - engleski - Ministry of Health

teva pharmaceutical industries ltd, israel - etodolac - tablets - etodolac 400 mg - etodolac - for the management of signs and symptoms of osteoarthritis and rheumatoid arthritis. for the management of pain.

Izrael - engleski - Ministry of Health

megapharm ltd - glyceryl trinitrate - solution - glyceryl trinitrate 0.4 mg/dose - glyceryl trinitrate - glyceryl trinitrate - relief of angina pectoris attacks, angina pectoris prophylaxis.

Izrael - engleski - Ministry of Health

rekah pharmaceutical industry ltd, israel - quinidine sulfate - tablets - quinidine sulfate 200 mg - antiarrhythmics, class ia - treatment of certain cardiac arrhythmias: atrial fibrillation / flutter and ventricular arrhythmias

Izrael - engleski - Ministry of Health

rekah pharmaceutical industry ltd, israel - benzoic acid as sodium; codeine phosphate; ephedrine hydrochloride; guaiacolsulfonate as potassium - syrup - guaiacolsulfonate as potassium 125 mg / 5 ml; ephedrine hydrochloride 6 mg / 5 ml; benzoic acid as sodium 20 mg / 5 ml; codeine phosphate 2 mg / 5 ml - opium alkaloids and derivatives - for relief of cough.

Izrael - engleski - Ministry of Health

rekah pharmaceutical industry ltd, israel - benzoic acid as sodium; codeine phosphate; ephedrine hydrochloride; guaiacolsulfonate as potassium - syrup - benzoic acid as sodium 20 mg / 5 ml; ephedrine hydrochloride 6 mg / 5 ml; guaiacolsulfonate as potassium 125 mg / 5 ml; codeine phosphate 2 mg / 5 ml - opium alkaloids and derivatives - for relief of cough.

Izrael - engleski - Ministry of Health

unipharm ltd, israel - simvastatin - film coated tablets - simvastatin 20 mg - simvastatin - simvastatin - coronary heart disease : in patients with coronary heart disease and hypercholesterolemia simvacor is indicated to: reduce the risk of total mortality by reducing coronary death reduce the risk of non-fatal myocardial infarction reduce the risk for undergoing myocardial revascularization procedures.reduce the risk of stroke and transient ischemic attacks (tia).hyperlipidemia: simvacor is indicated as an adjunct to diet to reduce elevated total-c ldl-c apo b and tg and to increase hdl-c in patients with primary hypercholesterolemia( heterozygous familial and nonfamilial) and mixed dyslipidemia (frederickson types iia and iib) simvacor therefore lowers the ldl-c/hdl-c and the total-c/hdl-c ratios.homozygous familial hypercholesterolemia: simvacor is also indicated as an adjunct to diet and other non-dietary measures in reducing elevated total cholesterol ldl-cholesterol and apolipoprotein b in patients with homozygous familial hypercholesterolemia when response to these measures is inadequate. hypertrigly

Izrael - engleski - Ministry of Health

unipharm ltd, israel - simvastatin - film coated tablets - simvastatin 10 mg - simvastatin - simvastatin - coronary heart disease : in patients with coronary heart disease and hypercholesterolemia simvacor is indicated to: reduce the risk of total mortality by reducing coronary death reduce the risk of non-fatal myocardial infarction reduce the risk for undergoing myocardial revascularization procedures. reduce the risk of stroke and transient ischemic attacks (tia). hyperlipidemia: simvacor is indicated as an adjunct to diet to reduce elevated total-c ldl-c apo b and tg and to increase hdl-c in patients with primary hypercholesterolemia( heterozygous familial and nonfamilial) and mixed dyslipidemia (frederickson types iia and iib) simvacor therefore lowers the ldl-c/hdl-c and the total-c/hdl-c ratios. homozygous familial hypercholesterolemia: simvacor is also indicated as an adjunct to diet and other non-dietary measures in reducing elevated total cholesterol ldl-cholesterol and apolipoprotein b in patients with homozygous familial hypercholesterolemia when response to these measures is inadequate. hypertri

Izrael - engleski - Ministry of Health

unipharm ltd, israel - simvastatin - film coated tablets - simvastatin 40 mg - simvastatin - simvastatin - coronary heart disease : in patients with coronary heart disease and hypercholesterolemia simvacor is indicated to: reduce the risk of total mortality by reducing coronary death reduce the risk of non-fatal myocardial infarction reduce the risk for undergoing myocardial revascularization procedures. reduce the risk of stroke and transient ischemic attacks (tia). hyperlipidemia: simvacor is indicated as an adjunct to diet to reduce elevated total-c ldl-c apo b and tg and to increase hdl-c in patients with primary hypercholesterolemia( heterozygous familial and nonfamilial) and mixed dyslipidemia (frederickson types iia and iib) simvacor therefore lowers the ldl-c/hdl-c and the total-c/hdl-c ratios.homozygous familial hypercholesterolemia: simvacor is also indicated as an adjunct to diet and other non-dietary measures in reducing elevated total cholesterol ldl-cholesterol and apolipoprotein b in patients with homozygous familial hypercholesterolemia when response to these measures is inadequate. hypertrig

Izrael - engleski - Ministry of Health

unipharm ltd, israel - simvastatin - film coated tablets - simvastatin 80 mg - simvastatin - simvastatin - coronary heart disease : in patients with coronary heart disease and hypercholesterolemia simvacor is indicated to: reduce the risk of total mortality by reducing coronary death reduce the risk of non-fatal myocardial infarction reduce the risk for undergoing myocardial revascularization procedures. reduce the risk of stroke and transient ischemic attacks (tia). hyperlipidemia: simvacor is indicated as an adjunct to diet to reduce elevated total-c ldl-c apo b and tg and to increase hdl-c in patients with primary hypercholesterolemia( heterozygous familial and nonfamilial) and mixed dyslipidemia (frederickson types iia and iib) simvacor therefore lowers the ldl-c/hdl-c and the total-c/hdl-c ratios. homozygous familial hypercholesterolemia: simvacor is also indicated as an adjunct to diet and other non-dietary measures in reducing elevated total cholesterol ldl-cholesterol and apolipoprotein b in patients with homozygous familial hypercholesterolemia when response to these measures is inadequate. hypertri